State Street Corp Orgenesis Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Orgenesis Inc. stock. As of the latest transaction made, State Street Corp holds 78,878 shares of ORGS stock, worth $94,653. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,878
Previous 67,659
16.58%
Holding current value
$94,653
Previous $55,000
14.55%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ORGS
# of Institutions
16Shares Held
1.54MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA910KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA283KShares$339,6920.0% of portfolio
-
Black Rock Inc. New York, NY79.9KShares$95,8660.0% of portfolio
-
Ronit Capital LLP54.2KShares$65,0000.1% of portfolio
-
Northern Trust Corp Chicago, IL40.5KShares$48,6140.0% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $30.7M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...